Okay this does look like a good announcement.
The journal is a good one, it was only published online today, the quote from John Rasko at the bottom is timely and paints a generous big picture and there is a link to the clinical trial so it ties in academic credibility with practical references readers of either the article (and its open source so free to read without a subscription) or the announcement to the trial.
Good job on this Kilian. It would be rare I think for biotech CEOs to be lead authors in nature medicine publications - I think this is a first for Cynata at least.
Hope it helps the recruitment rate.
Ann: Further GvHD Clinical Data Published in Nature Medicine, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
-0.015(8.82%) |
Mkt cap ! $35.02M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 15.5¢ | $35.01K | 213.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 201289 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 14675 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| CYP (ASX) Chart |